Abstract:The determination of metabolic stability is critical for drug discovery programs, allowing for the optimization of chemical entities and compound prioritization. As such, it is common to perform high-volume in vitro metabolic stability experiments early in the lead optimization process to understand metabolic liabilities. Additional metabolite identification experiments are subsequently performed for a more comprehensive understanding of the metabolic clearance routes to aid medicinal chemists in the structural design of compounds. Collectively, these experiments require extensive sample preparation and a substantial amount of time and resources. To overcome the challenges, a high-throughput integrated assay for simultaneous hepatocyte metabolic stability assessment and metabolite profiling was developed. This assay platform consists of four parts: 1) an automated liquid-handling system for sample preparation and incubation, 2) a liquid chromatography and high-resolution mass spectrometry-based system to simultaneously monitor the parent compound depletion and metabolite formation, 3) an automated data analysis and report system for hepatic clearance assessment; and 4) streamlined autobatch processing for software-based metabolite profiling. The assay platform was evaluated using eight control compounds with various metabolic rates and biotransformation routes in hepatocytes across three species. Multiple sample preparation and data analysis steps were evaluated and validated for accuracy, repeatability, and metabolite coverage. The combined utility of an automated liquid-handling instrument, a high-resolution mass spectrometer, and multiple streamlined data processing software improves the process of these highly demanding screening assays and allows for simultaneous determination of metabolic stability and metabolite profiles for more efficient lead optimization during early drug discovery. SIGNIFICANCE STATEMENT: Metabolic stability assessment and metabolite profiling are pivotal in drug discovery to fully comprehend metabolic liabilities for chemical entity optimization and lead selection. Process of these assays can be repetitive and resource demanding. Here, we developed an integrated hepatocyte stability assay that combines automation, high-resolution mass spectrometers, and batch-processing software to improve and combine the workflow of these assays. The integrated approach allows simultaneous metabolic stability assessment and metabolite profiling, significantly accelerating screening and lead optimization in a resource-effective manner.

[Application and Development of in Vitro Metabolism Study at Early Drug Discovery Stage].

Prediction of Metabolic Drug Interaction in vivo by Using in vitro Drug Metabolism Data

Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap.

The conduct of drug metabolism studies considered good practice (II): in vitro experiments.

Advantages,disadvantages and applications of in vitro hepatic metabolic models

[Advances and Related Issues in the Use of in Vitro Methods to Predict Metabolic Clearance Rate of New Drugs].

Drug metabolism in drug discovery and development

The Conduct Of Drug Metabolism Studies Considered Good Practice (I): Analytical Systems And In Vivo Studies

Drug metabolic stability in early drug discovery to develop potential lead compounds

High Throughput Screening of in Vitro ADMET Profiling in Drug Discovery

The Current State of Biotransformation Science – Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends

In silico prediction of cytochrome P450-mediated drug metabolism.

Application of in vivo solid phase microextraction in exploring dynamic metabolic alterations in living organisms under exogenous stimulation

An Integrated Hepatocyte Stability Assay for Simultaneous Metabolic Stability Assessment and Metabolite Profiling

Early Metabolism Evaluation Making Traditional Chinese Medicine Effective and Safe Therapeutics

Metabolomics: Bridging Chemistry and Biology in Drug Discovery and Development

Novel in vitro dynamic metabolic system for predicting the human pharmacokinetics of tolbutamide

Prediction of metabolizing enzyme-mediated clinical drug interactions using in vitro information

Recent Methods and Strategies for in vivo Metabolic Study of Traditional Chinese Medicines

Research Progress in Novel Predictive Method of Drug Metabolic Toxicity in Vitro

Development of Metabonomics and Its Application in Drug Safety Evaluation